Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide plus Fulvestrant in HR+/HER2- Advanced Breast Cancer
NCT05808582Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tucidinostat in breast cancer, sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05808582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05808582.